CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07.
Published October 8, 2014 · Recall initiated: September 15, 2014
Summary
FDA records drug Class II recall D-1611-2014, published October 8, 2014 and initiated September 15, 2014. Recalling firm: AbbVie Inc; Status: Terminated; Reported quantity: 18,021 Bottles; Lot: Lot #: 1020156; Expiry: 3/31/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
What to do
Voluntary: Firm initiated · Letter
Get an email if CREON has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CREON
- Manufacturer
- AbbVie Inc
- Distributor
- US: Nationwide
- UPC
- 0300322637701
- Lot
- Lot #: 1020156; Expiry: 3/31/2016
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACreon (pancrelipase) Delayed-Release Capsules Dose By Lipase Units Lipase 36,000 USP Units Rx only NDCJune 2, 2021
- FDADianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, 5000 mL Ambu-Flex IIOctober 8, 2014
- FDABlack Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.October 8, 2014
- FDADOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02.October 8, 2014
- FDAMOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Springville, UT 84663October 8, 2014
- FDAAll sterile drugs compounded between 2/21/14 and 2/24/14.October 8, 2014
Questions about this recall
Was CREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. Marketed by: AbbVie Inc., North Chicago, IL 60064, Product of Germany. NDC 0032-1224-07. recalled?
Yes. FDA published recall D-1611-2014 on October 8, 2014. Reported hazard: Presence of Foreign Tablets/Capsules; Presence of co-mingled LipaCreon 13000.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CREON. UPC: 0300322637701.